Litigation Details for Rochester Drug Co-Operative, Inc. v. Shire LLC (D. Mass. 2017)
✉ Email this page to a colleague
Rochester Drug Co-Operative, Inc. v. Shire LLC (D. Mass. 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-01-10 |
| Court | District Court, D. Massachusetts | Date Terminated | 2017-11-20 |
| Cause | 15:1 Antitrust Litigation | Assigned To | Allison Dale Burroughs |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 6,287,599; 6,811,794 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in Rochester Drug Co-Operative, Inc. v. Shire LLC
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for Rochester Drug Co-Operative, Inc. v. Shire LLC (D. Mass. 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2017-01-10 | 1 | 5,854,290 (the ’290 patent), 6,287,599 (the ’599 patent), and 6,811,794 (the ’794 patent). 56. The…drug prior to the expiration of the listed patent(s). Patents issued after NDA approval may be listed in…verify the manufacturer’s patents for accuracy or trustworthiness. In listing patents in the Orange Book, the…listed several patents in the Orange Book as covering Intuniv, specifically, U.S. Patent Nos. 5,854,290…The ’290 patent is a method of use patent, entitled “Use of guanfacine in the treatment of behavioral disorders | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
